Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sevier, Marcus
NCT05704803: COVID-19 Molecular OTC At Home Test	Completed	N/A	202	US	Diagnostic Test: IN Vitro	3EO Health	COVID-19 Pandemic	04/23	04/23
Basaldua, Martin
CYPRESS, NCT05895552: A Phase 2 Study of RTA 901 (BIIB143) in Participants With Diabetic Peripheral Neuropathic Pain	Recruiting	2	384	US	RTA 901, BIIB143, Cemdomespib, RTA 901-Matching Placebo	Reata, a wholly owned subsidiary of Biogen	Diabetic Peripheral Neuropathic Pain	08/26	08/26
NCT05704803: COVID-19 Molecular OTC At Home Test	Completed	N/A	202	US	Diagnostic Test: IN Vitro	3EO Health	COVID-19 Pandemic	04/23	04/23
SHIELD, NCT05117840: Screening for High Frequency Malignant Disease	Active, not recruiting	N/A	12000	Europe, US	Low-dose CT scan	Guardant Health, Inc.	Lung Cancer	12/24	12/25